SALLIE STALEY: Open Payments
NPI 1821068768 · MOUNT AIRY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 19 payments from 11 companies in 2025. Trend: 2023 $911 · 2024 $50 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $78 |
| Aveo Pharmaceuticals, Inc. | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| BeOne Medicines USA, Inc. | 2 | $37 |
| Celgene Corporation | 2 | $34 |
| Gilead Sciences, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $30 |
| Eisai Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: FOTIVDA, Nubeqa, BRUKINSA, REBLOZYL, Trodelvy, VENCLEXTA, RYBREVANT, TECVAYLI.
Industry payments across NC — which companies pay providers there.
